NCT01962428View on ClinicalTrials.gov

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

PHASE4CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Non ST Segment Elevation Acute Coronary Syndrome

Interventions

DRUG

ticagrelor

Patients will receive ticagrelor 360mg loading dose or 180mg loading dose , then 90mg bid maintenance dose starting 12 hours after loading dose.

Trial Locations (2)

100039

General Hospital of Chinese People's Armed Police Forces, Beijing

Unknown

General Hospital of Chinese People's Armed Police Forces, Beijing

All Listed Sponsors

lead

General Hospital of Chinese Armed Police Forces

OTHER

NCT01962428 - Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI | Biotech Hunter | Biotech Hunter